The South & Central America blood collection devices market is expected to grow from US$ 333.95 million in 2022 to US$ 521.55 million by 2030. It is estimated to grow at a CAGR of 5.7% from 2022 to 2030.
Blood collection devices are used for drawing blood from the veins. According to the World Health Organization, the most noncommunicable disease-related deaths are cardiovascular diseases, accounting for ∼17 million people each year, followed by cancers, chronic respiratory diseases, and diabetes (including deaths associated with the kidney). Furthermore, the needles are used for drawing blood for cholesterol testing as high cholesterol can cause heart stroke and heart attack. According to the World Heart Federation, high cholesterol causes 4.4 million deaths yearly, and ∼24% of cardiovascular-related deaths are attributable to high low-density lipoprotein (LDL) cholesterol. Further, diabetes is a life-threatening chronic disease with no practical cure. Diabetes can lead to several complications in different body parts and increase the probability of premature death. Heart attack, kidney failure, stroke, vision loss, leg amputation, and nerve damage are the major complications associated with diabetes. As per the International Diabetes Federation (IDF), in 2021, ∼537 million adults suffered from diabetes worldwide. The number is anticipated to reach 643 million and 783 million by 2030 and 2045, respectively. The treatment of chronic diseases requires blood tests and long-term medications; hence, the growing incidence of chronic diseases is anticipated to create numerous growth opportunities for the market players in the coming years.
Brazil has a significant medical device industry, and it is the largest of all Latin American countries. According to the International Trade Administration (US Department of Commerce), the medical device industry in Brazil relies mainly on the US, China, and Germany. In 2021, the country reported an increase of 7.3% in the imports of medical devices, reaching the value of US$ 6.2 billion. As per estimates by the Brazilian Ministry of Health, ~3 million units of blood are collected each year in Brazil; out of the total blood collected, ~70% of donations in these regions are collected through the public system. According to the Global Burden of Disease data published in 2020, Brazil has a high prevalence of chronic obstructive pulmonary disease (COPD), diabetes, and ischemic heart disease. Additionally, ischemic heart disease, stroke, COPD, and diabetes were the leading cause of death among the Brazilian population between 2009 and 2019. Thus, the country provides lucrative opportunities for companies providing blood collection devices for blood donation and disease diagnostics.
The South & Central America blood collection devices market is segmented into product type, methods, end user, and country.
Based on product type, the South & Central America blood collection devices Market is segmented into blood collection tubes, blood collection needles/holders, blood collection set, and others. The blood collection tubes segment held the largest share of the South & Central America blood collection devices market in 2022.
In terms of methods, the South & Central America blood collection devices Market is bifurcated into manual blood collection and automated blood collection. The manual blood collection segment held a larger share of the South & Central America blood collection devices market in 2022.
By end user, the South & Central America blood collection devices market is segmented into hospitals and pathology laboratories, blood bank, and others. The hospitals and pathology laboratories segment held the largest share of the South & Central America blood collection devices market in 2022.
Based on country, the South & Central America blood collection devices market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated South & Central America blood collection devices market in 2022.
Becton Dickenson and Co, Terumo Corp, Cardinal Health, SARSTEDT AG & Co. KG, NIPRO, Thermo Fisher Scientific Inc, Sekisui Chemical Co Ltd, and Greiner Bio One International GmBH are some of the leading companies operating in the South & Central America blood collection devices market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 333.95 Million |
| Market Size by 2030 | US$ 521.55 Million |
| CAGR (2022 - 2030) | 5.7% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2030 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
South and Central America
|
| Market leaders and key company profiles |
|
The South & Central America Blood Collection Devices Market is valued at US$ 333.95 Million in 2022, it is projected to reach US$ 521.55 Million by 2030.
As per our report South & Central America Blood Collection Devices Market, the market size is valued at US$ 333.95 Million in 2022, projecting it to reach US$ 521.55 Million by 2030. This translates to a CAGR of approximately 5.7% during the forecast period.
The South & Central America Blood Collection Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Blood Collection Devices Market report:
The South & Central America Blood Collection Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South & Central America Blood Collection Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South & Central America Blood Collection Devices Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South & Central America Blood Collection Devices Market
